Your browser doesn't support javascript.
loading
Research priorities for expanding access to methadone treatment for opioid use disorder in the United States: A National Institute on Drug Abuse Center for Clinical Trials Network Task Force report.
Joudrey, Paul J; Bart, Gavin; Brooner, Robert K; Brown, Lawrence; Dickson-Gomez, Julie; Gordon, Adam; Kawasaki, Sarah S; Liebschutz, Jane M; Nunes, Edward; McCarty, Dennis; Schwartz, Robert P; Szapocnik, José; Trivedi, Madhukar; Tsui, Judith I; Williams, Arthur; Wu, Li-Tzy; Fiellin, David A.
Afiliação
  • Joudrey PJ; Program in Addiction Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, USA.
  • Bart G; Department of Medicine, Hennepin Healthcare, Minneapolis, Minnesota, USA.
  • Brooner RK; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University, Baltimore, Maryland, USA.
  • Brown L; START Treatment and Recovery Centers, Brooklyn, New York, USA.
  • Dickson-Gomez J; Department of Psychiatry and Behavioral Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
  • Gordon A; Department of Internal Medicine, University of Utah, Salt Lake City, Utah, USA.
  • Kawasaki SS; Department of Psychiatry and Behavioral Health, Penn State University, State College, Pennsylvania, USA.
  • Liebschutz JM; Center for Research on Health Care, Division of General Internal Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Nunes E; Department of Psychiatry, Columbia University Irving Medical Center, New York, New York, USA.
  • McCarty D; Department of Public Health & Preventive Medicine, Oregon Health & Science University, Portland, Oregon, USA.
  • Schwartz RP; Friends Research Institute, Baltimore, MD, USA.
  • Szapocnik J; Department of Public Health Sciences, University of Miami, Coral Gables, Florida, USA.
  • Trivedi M; Division of Mood Disorders, Department of Psychiatry, UT Southwestern Medical Center, Dallas, Texas, USA.
  • Tsui JI; Division of General Internal Medicine, Department of Internal Medicine, University of Washington, Seattle, Washington, USA.
  • Williams A; Division on Substance Use Disorders, Department of Psychiatry, Columbia University, New York, New York, USA.
  • Wu LT; Department of Medicine and Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, North Carolina, USA.
  • Fiellin DA; Program in Addiction Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, USA.
Subst Abus ; 42(3): 245-254, 2021.
Article em En | MEDLINE | ID: mdl-34606426
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Buprenorfina / Transtornos Relacionados ao Uso de Opioides Tipo de estudo: Prognostic_studies Limite: Humans País/Região como assunto: America do norte Idioma: En Revista: Subst Abus Assunto da revista: TRANSTORNOS RELACIONADOS COM SUBSTANCIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Buprenorfina / Transtornos Relacionados ao Uso de Opioides Tipo de estudo: Prognostic_studies Limite: Humans País/Região como assunto: America do norte Idioma: En Revista: Subst Abus Assunto da revista: TRANSTORNOS RELACIONADOS COM SUBSTANCIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos